Work

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. Cancers 2023, 15, 3726

Year: 2023

Type: erratum

Abstract: It has come to our attention that the previously published manuscript contained an outdated iteration of Table 1 [...].

Source: Cancers

DOI: 10.3390/cancers16010119

Authors: Marco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, Akane Yamamichi, Hideho Okada

Institutions: University of California, San Francisco, University Hospital Münster, Parker Institute for Cancer Immunotherapy, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,892

Funders: Deutsche Forschungsgemeinschaft, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression, G7440174680, Preclinical development of breakthrough immunotherapy for brain tumors

OpenAlex ID: W4390231676

Cites: 1

Cited by:

Related to: 10